verve therapeutics eli lilly - Search News

News

Eli Lilly Buys Verve Therapeutics

The Motley Fool on MSN · 46m

Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week

Shares in Verve Therapeutics (NASDAQ: VERV) soared 80.5% this week on the news of an agreement for Eli Lilly (NYSE: LLY) to acquire Verve. The deal centers on an exciting cardiovascular health medicine program,

The Wall Street Journal on MSN · 3d

Eli Lilly to Acquire Verve Therapeutics for Up to $1.3 Billion

Eli Lilly agreed to acquire Verve Therapeutics for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio. Under the agreement, the pharmaceutical company will buy all of the gene-editing startup’s shares outstanding for $10.

Beyond Obesity: Eli Lilly’s Genetic Medicine Bet On Verve Therapeutics

The acquisition aligns with Eli Lilly’s broader diversification strategy beyond its core diabetes and obesity treatment portfolio.

Eli Lilly to Acquire Verve Therapeutics for $1 Billion

With acquisition of Verve Therapeutics, Eli Lilly aims to advance next-generation cardiovascular care through one-time gene ...

2don MSN

This one-and-done heart-disease treatment just got a $1.3 billion endorsement from Eli Lilly

Eli Lilly & Co. aims to offer a one-and-done heart-disease medicine by paying up to $1.3 billion for Verve Therapeutics Inc., ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results